SPDL1 and hepatocellular carcinoma: Likewise, hepatocellular carcinoma patients receiving concurrent chemoradiotherapy displayed increased sPD-L1 levels post-RT which decreased back to baseline levels at 1 month while SBRT receiving patients exhibited a continued increase until 1 month (183).